Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Viking Therapeutics Inc., 3 years.
Viking Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 2, 2026 | Viking Therapeutics Inc. | Grant or award | +3,150 | — | — |
| Nov 8, 2024 | Viking Therapeutics Inc. | Option exercise | +2,000 | $5.80 | $11,600 |
| Nov 8, 2024 | Viking Therapeutics Inc. | Open-market sale | −2,000 | $68.67 | $137,340 |
| May 16, 2023 | Viking Therapeutics Inc. | Option exercise | +16,000 | $1.19 | $19,040 |
| May 16, 2023 | Viking Therapeutics Inc. | Open-market sale | −16,000 | $24.00 | $384,000 |
| Apr 24, 2023 | Viking Therapeutics Inc. | Option exercise | +16,000 | $3.33 | $53,280 |
| Apr 24, 2023 | Viking Therapeutics Inc. | Open-market sale | −16,000 | $22.00 | $352,000 |
| Apr 17, 2023 | Viking Therapeutics Inc. | Option exercise | +20,786 | $8.00 | $166,288 |
| Apr 17, 2023 | Viking Therapeutics Inc. | Open-market sale | −20,786 | $20.00 | $415,720 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.